loading page

Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: a systematic review and meta-analysis
  • +2
  • Renan Pereira,
  • Versiéri Almeida,
  • Mariana Zambrano,
  • Linjie Zhang,
  • Sérgio Amantéa
Renan Pereira
Universidade Federal de Ciências da Saúde de Porto Alegre
Author Profile
Versiéri Almeida
Universidade Federal de Ciências da Saúde de Porto Alegre
Author Profile
Mariana Zambrano
Universidade Federal de Ciências da Saúde de Porto Alegre
Author Profile
Linjie Zhang
Universidade Federal do Rio Grande
Author Profile
Sérgio Amantéa
Universidade Federal de Ciências da Saúde de Porto Alegre
Author Profile

Abstract

Management of acute bronchiolitis remains controversial due to lack of strong evidence-based data. Nebulized epinephrine and hypertonic saline have been studied in infants with bronchiolitis, with conflicting results. This systematic review and meta-analysis aimed to evaluate the efficacy on length of stay (LOS), clinical severity scores (CSS), oxygen saturation (SaO2) and safety profile of nebulized epinephrine plus hypertonic saline (HS) in infants with acute bronchiolitis. Outcomes were represented by mean differences (MD) or standard mean differences (SMD) and 95% confidence intervals (CIs) were utilized. 18 trials were systematically selected and 16 of them contributed for the meta-analysis (1,756 patients). Overall, a modest but significant positive impact was observed of the combination therapy on LOS (MD of – 0.35 days, 95% CI -0.62 to -0.08, p = 0.01, I2 = 91%). Stratification by time of CSS assessment unveiled positive results in favor of the combination therapy in CSS assessed 48 hours and 72 hours after the admission (SMD of -0.35, 95% CI -0.62 to -0.09, p = 0.008, I2 = 41% and SMD of -0.27, 95% CI -0.50 to -0.04, p = 0.02, I2 = 0%, respectively). No difference in SaO2 was observed. Additional data showed a consistent safety profile, with a low rate of adverse events (1%), most of them mild and transient. In conclusion, nebulized epinephrine plus HS may be considered as a safe, cheap and efficient alternative for decreasing LOS and CSS in infants with acute bronchiolitis, especially on those who require more than 48 hours of hospitalization.

Peer review status:IN REVISION

14 May 2021Submitted to Pediatric Pulmonology
14 May 2021Assigned to Editor
14 May 2021Submission Checks Completed
16 May 2021Reviewer(s) Assigned
03 Jun 2021Review(s) Completed, Editorial Evaluation Pending
07 Jun 2021Editorial Decision: Revise Major